Cwm, LLC Pliant Therapeutics, Inc. Transaction History

Cwm, LLC

$23.3 Billion
Q3 2024

A detailed history of Cwm, LLC transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Cwm, LLC holds 479 shares of PLRX stock, worth $5,901. This represents 0.0% of its overall portfolio holdings.

Number of Shares

479

Holding current value

$5,901

% of portfolio

0.0%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$10.52 - $14.35 $5,039 - $6,873	479 New	479 $5,000
Q1 2024 Apr 05, 2024	BUY	$14.14 - $19.59 $14 - $19	1 New	1 $0
Q3 2023 Oct 11, 2023	BUY	$14.58 - $20.15 $102 - $141	7 New	7 $0

Others Institutions Holding PLRX

# of Institutions

168

Shares Held

63.2M

Call Options Held

245K

Put Options Held

373K

Deep Track Capital, LP Greenwich, CT

5.97M
Shares

$73.6 Million
2.47% of portfolio
Black Rock Inc. New York, NY

4.97M
Shares

$61.3 Million
0.0% of portfolio
Price T Rowe Associates Inc Baltimore, MD

4.83M
Shares

$59.6 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

3.53M
Shares

$43.4 Million
0.0% of portfolio
Redmile Group, LLC San Francisco, CA

3.2M
Shares

$39.4 Million
2.34% of portfolio

View Full List

About PLIANT THERAPEUTICS, INC.

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

More about PLRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account